Windward Bio Group AG filed a Form 8-A12B on November 9, 2026, registering its common shares, CHF 0.015 par value per share, for listing on The Nasdaq Stock Market LLC.

Key Highlights

  • Registrant: Windward Bio Group AG, incorporated in Switzerland, with principal offices at Aeschenplatz 6, Basel, Switzerland 4052.
  • Security registered: Common Shares with a par value of CHF 0.015 per share, registered under Section 12(b) of the Securities Exchange Act of 1934.
  • Exchange: The securities are being registered on NASDAQ:WWB, as listed on The Nasdaq Stock Market LLC.
  • Related filing: The registration is linked to Form F-1 Registration Statement, File No. 333-299608, originally filed with the SEC on October 23, 2026.
  • No exhibits required: The filing states no exhibits are required because no other Windward Bio Group AG securities are registered on Nasdaq and the shares are not being registered under Section 12(g).
  • Signed by: Scott Applebaum, Chief Legal and Corporate Development Officer, on behalf of the registrant.

Windward Bio Group AG Registers Common Shares Under Section 12(b)

According to the filing, Windward Bio Group AG submitted a Form 8-A to register its common shares, par value CHF 0.015 per share, for trading on The Nasdaq Stock Market LLC. The registration is effective pursuant to Section 12(b) of the Securities Exchange Act of 1934, as indicated by the checked box on the form. The company is organized under the laws of Switzerland and has listed no I.R.S. Employer Identification Number, noting "Not applicable" in that field.

The filing discloses that the description of the common shares is incorporated by reference from the section titled "Description of Share Capital and Articles of Association" contained in the company's Registration Statement on Form F-1, File No. 333-299608. That Form F-1 was originally filed with the Securities and Exchange Commission on October 23, 2026, and has been subsequently amended, according to the filing. The filing also notes that the prospectus to be filed under Rule 424(b) of the Securities Act of 1933 will be deemed incorporated by reference into the Form 8-A.

Regarding exhibits, the filing states that none are required to be filed, explaining that "no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended." The registration statement was signed by Scott Applebaum, identified as Chief Legal and Corporate Development Officer, on November 9, 2026.

What Was Disclosed

Windward Bio Group AG filed a Form 8-A12B on November 9, 2026, to register its CHF 0.015 par value common shares on The Nasdaq Stock Market LLC under Section 12(b), incorporating the share description by reference from its previously filed Form F-1 (File No. 333-299608).